EKS-RAN-00136
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-RAN-00136
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
AGC/Akt503.91.2E-151150408259
StatusReviewed
Ensembl ProteinENSRNOP00000038369
UniProt AccessionP47196;
Protein NameRAC-alpha serine/threonine-protein kinase
Protein Synonyms/Alias Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; RAC-PK-alpha;
Gene NameAkt1
Gene Synonyms/Alias Akt1;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSRNOG00000028629ENSRNOP00000038369ENSRNOT00000031164
OrganismRattus norvegicus
Functional DescriptionAKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)- response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr- 117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (By similarity). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro-apoptotic activity (By similarity). AKT1-specific substrates have been recently identified,including palladin (PALLD), which phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation.
Protein Length480
Protein Sequence
(FASTA)
MNDVAIVKEG WLHKRGEYIK TWRPRYFLLK NDGTFIGYKE RPQDVEQRES PLNNFSVAQC 60
QLMKTERPRP NTFIIRCLQW TTVIERTFHV ETPEEREEWT TAIQTVADGL KRQEEETMDF 120
RSGSPSDNSG AEEMEVALAK PKHRVTMNEF EYLKLLGKGT FGKVILVKEK ATGRYYAMKI 180
LKKEVIVAKD EVAHTLTENR VLQNSRHPFL TALKYSFQTH DRLCFVMEYA NGGELFFHLS 240
RERVFSEDRA RFYGAEIVSA LDYLHSEKNV VYRDLKLENL MLDKDGHIKI TDFGLCKEGI 300
KDGATMKTFC GTPEYLAPEV LEDNDYGRAV DWWGLGVVMY EMMCGRLPFY NQDHEKLFEL 360
ILMEEIRFPR TLGPEAKSLL SGLLKKDPTQ RLGGGSEDAK EIMQHRFFAN IVWQDVYEKK 420
LSPPFKPQVT SETDTRYFDE EFTAQMITIT PPDQDDSMEC VDSERRPHFP QFSYSASGTA 480
Nucleotide Sequence
(FASTA)
ATGAACGACG TAGCCATTGT GAAGGAGGGC TGGCTGCACA AACGAGGGGA ATATATTAAA 60
ACCTGGCGGC CACGCTACTT CCTCCTCAAG AATGATGGCA CCTTTATTGG CTACAAGGAA 120
CGGCCTCAGG ATGTGGAGCA GCGCGAGTCC CCACTCAACA ACTTCTCAGT GGCACAATGT 180
CAGCTGATGA AGACAGAGCG GCCGAGGCCC AACACCTTCA TCATCCGCTG CCTGCAGTGG 240
ACCACGGTCA TTGAGCGCAC CTTCCATGTG GAAACGCCTG AGGAGCGGGA AGAGTGGACC 300
ACCGCCATTC AGACTGTGGC TGATGGACTC AAACGGCAGG AGGAGGAGAC GATGGACTTC 360
CGGTCAGGTT CACCCAGTGA CAACTCAGGT GCTGAGGAGA TGGAGGTGGC CCTGGCCAAG 420
CCCAAGCACC GTGTGACCAT GAACGAGTTT GAGTACCTGA AGCTACTGGG CAAGGGCACC 480
TTTGGGAAGG TGATCCTGGT GAAGGAGAAG GCCACAGGTC GCTACTATGC CATGAAGATC 540
CTCAAGAAGG AGGTCATCGT TGCCAAGGAT GAGGTTGCCC ACACGCTTAC TGAGAACCGT 600
GTCCTGCAGA ACTCTAGGCA TCCCTTCCTT ACAGCCCTCA AGTACTCATT CCAGACCCAC 660
GACCGCCTCT GCTTTGTCAT GGAGTACGCC AATGGGGGCG AGCTCTTCTT CCACCTGTCT 720
CGTGAGCGCG TGTTTTCAGA GGACCGGGCC CGCTTCTACG GTGCGGAGAT TGTGTCCGCC 780
CTGGACTACT TGCACTCCGA GAAGAACGTG GTGTACCGGG ACCTCAAGCT GGAGAACCTC 840
ATGCTGGACA AGGACGGGCA CATCAAGATA ACGGACTTCG GGCTGTGCAA GGAGGGTATC 900
AAGGACGGTG CCACCATGAA GACGTTCTGC GGGACACCCG AGTACCTGGC CCCTGAGGTG 960
CTGGAGGACA ACGACTATGG CCGTGCAGTG GACTGGTGGG GGCTGGGCGT GGTCATGTAC 1020
GAGATGATGT GCGGCCGCCT GCCCTTCTAC AACCAGGACC ATGAGAAGCT GTTCGAGCTC 1080
ATCCTAATGG AGGAGATCCG CTTCCCACGC ACACTCGGGC CGGAGGCCAA GTCCCTGCTC 1140
TCGGGGCTGC TCAAGAAGGA CCCTACACAG AGGCTCGGTG GGGGCTCCGA GGACGCCAAG 1200
GAGATCATGC AGCACCGCTT CTTTGCCAAC ATCGTGTGGC AAGATGTGTA TGAGAAGAAG 1260
CTGAGCCCAC CTTTCAAGCC CCAGGTCACC TCTGAGACCG ACACCAGGTA TTTTGATGAG 1320
GAGTTCACAG CTCAGATGAT CACCATCACG CCGCCTGATC AAGATGACAG CATGGAGTGT 1380
GTGGACAGTG AACGGAGGCC GCACTTTCCC CAGTTCTCCT ACTCAGCCAG TGGCACAGCC 1440
TGA 1443
Domain Profile
S: 1     fdllkllGkGtfGkvilvrekatqklyalkilkkevivakdevahtlterrvlkrtkhpf  60
         f++lkllGkGtfGkvilv+ekat+++ya+kilkkevivakdevahtlte+rvl++++hpf
Q: 150   FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF  209
         9***********************************************************
S: 61    lvalkysfqtkeklclvleyvnGGelffhlskervfsedrarfygaeivsaldylhs.kd  119
         l+alkysfqt+++lc+v+ey+nGGelffhls+ervfsedrarfygaeivsaldylhs k+
Q: 210   LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSeKN  269
         ********************************************************9789
S: 120   vvyrdlklenllldkdGhikitdfGlckeeikdgdktktfcGtpeylapevlededygka  179
         vvyrdlklenl+ldkdGhikitdfGlcke+ikdg+++ktfcGtpeylapevled+dyg+a
Q: 270   VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA  329
         ************************************************************
S: 180   vdwwglGvvlyemlcGrlpfynkdheklfelilleelkfprklseeaksllsGllkkdpk  239
         vdwwglGvv+yem+cGrlpfyn+dheklfelil+ee++fpr+l++eaksllsGllkkdp+
Q: 330   VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPT  389
         ************************************************************
S: 240   krlGggkddakeireheff  258
         +rlGgg++dakei++h+ff
Q: 390   QRLGGGSEDAKEIMQHRFF  408
         ******************9
Domain Sequence
(FASTA)
FEYLKLLGKG TFGKVILVKE KATGRYYAMK ILKKEVIVAK DEVAHTLTEN RVLQNSRHPF 60
LTALKYSFQT HDRLCFVMEY ANGGELFFHL SRERVFSEDR ARFYGAEIVS ALDYLHSEKN 120
VVYRDLKLEN LMLDKDGHIK ITDFGLCKEG IKDGATMKTF CGTPEYLAPE VLEDNDYGRA 180
VDWWGLGVVM YEMMCGRLPF YNQDHEKLFE LILMEEIRFP RTLGPEAKSL LSGLLKKDPT 240
QRLGGGSEDA KEIMQHRFF 259
KeywordAcetylation; Apoptosis; ATP-binding; Carbohydrate metabolism; Cell membrane; Complete proteome; Cytoplasm; Developmental protein; Disulfide bond; Glucose metabolism; Glycogen biosynthesis; Glycogen metabolism; Glycoprotein; Kinase; Membrane; Neurogenesis; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Serine/threonine-protein kinase; Sugar transport; Transferase; Translation regulation; Transport; Ubl conjugation.
Sequence SourceEnsembl
Orthology
Ortholog group
Anolis carolinensis"; ?>Bos taurus"; ?>Caenorhabditis elegans"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Ciona intestinalis"; ?>Ciona savignyi"; ?>Equus caballus"; ?>Gallus gallus"; ?>Gorilla gorilla"; ?>Homo sapiens"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Monodelphis domestica"; ?>Mus musculus"; ?>Mustela putorius furo"; ?>Nomascus leucogenys"; ?>Oreochromis niloticus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pelodiscus sinensis"; ?>Petromyzon marinus"; ?>Procavia capensis"; ?>Pteropus vampyrus"; ?>Sarcophilus harrisii"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tetraodon nigroviridis"; ?>Xenopus tropicalis"; ?>Xiphophorus maculatus"; ?>
EKS-ANC-00133
EKS-BOT-00141
EKS-CAE-00113
EKS-CAF-00147
EKS-CAP-00138
EKS-CII-00086
EKS-CIS-00177
EKS-EQC-00138
EKS-GAG-00116
EKS-GOG-00140
EKS-HOS-00143
EKS-ICT-00132
EKS-LAC-00148
EKS-MAM-00138
EKS-MEG-00106
EKS-MOD-00137
EKS-MUM-00143
EKS-MUP-00144
EKS-NOL-00134
EKS-ORN-00171
EKS-ORL-00160
EKS-OTG-00144
EKS-PES-00123
EKS-PEM-00075
EKS-PRC-00020
EKS-PTV-00131
EKS-SAH-00133
EKS-TAG-00168
EKS-TAR-00183
EKS-TEN-00171
EKS-XET-00127
EKS-XIM-00166
Gene Ontology
GO:0005829; C:cytosol
GO:0030027; C:lamellipodium
GO:0005654; C:nucleoplasm
GO:0005886; C:plasma membrane
GO:0005819; C:spindle
GO:0005524; F:ATP binding
GO:0030235; F:nitric-oxide synthase regulator activity
GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding
GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding
GO:0004674; F:protein serine/threonine kinase activity
GO:0006924; P:activation-induced cell death of T cells
GO:0007568; P:aging
GO:0042640; P:anagen
GO:0008637; P:apoptotic mitochondrial changes
GO:0030030; P:cell projection organization
GO:0071364; P:cellular response to epidermal growth factor stimulus
GO:0071456; P:cellular response to hypoxia
GO:0007281; P:germ cell development
GO:0042593; P:glucose homeostasis
GO:0006006; P:glucose metabolic process
GO:0015758; P:glucose transport
GO:0005978; P:glycogen biosynthetic process
GO:0060709; P:glycogen cell differentiation involved in embryonic placenta development
GO:0006954; P:inflammatory response
GO:0008286; P:insulin receptor signaling pathway
GO:0048009; P:insulin-like growth factor receptor signaling pathway
GO:0060716; P:labyrinthine layer blood vessel development
GO:0001893; P:maternal placenta development
GO:0043066; P:negative regulation of apoptotic process
GO:0045792; P:negative regulation of cell size
GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0031999; P:negative regulation of fatty acid beta-oxidation
GO:0046329; P:negative regulation of JNK cascade
GO:0010748; P:negative regulation of plasma membrane long-chain fatty acid transport
GO:0006469; P:negative regulation of protein kinase activity
GO:0090201; P:negative regulation of release of cytochrome c from mitochondria
GO:0001649; P:osteoblast differentiation
GO:0018105; P:peptidyl-serine phosphorylation
GO:0032287; P:peripheral nervous system myelin maintenance
GO:0043065; P:positive regulation of apoptotic process
GO:0043536; P:positive regulation of blood vessel endothelial cell migration
GO:0030307; P:positive regulation of cell growth
GO:0032270; P:positive regulation of cellular protein metabolic process
GO:0031659; P:positive regulation of cyclin-dependent protein kinase activity involved in G1/S
GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane
GO:0045600; P:positive regulation of fat cell differentiation
GO:0046326; P:positive regulation of glucose import
GO:0045725; P:positive regulation of glycogen biosynthetic process
GO:0046889; P:positive regulation of lipid biosynthetic process
GO:0045429; P:positive regulation of nitric oxide biosynthetic process
GO:0051000; P:positive regulation of nitric-oxide synthase activity
GO:0033138; P:positive regulation of peptidyl-serine phosphorylation
GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process
GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity
GO:0010765; P:positive regulation of sodium ion transport
GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter
GO:0045907; P:positive regulation of vasoconstriction
GO:0030163; P:protein catabolic process
GO:0000060; P:protein import into nucleus, translocation
GO:0043491; P:protein kinase B signaling cascade
GO:0016567; P:protein ubiquitination
GO:0030334; P:regulation of cell migration
GO:0010975; P:regulation of neuron projection development
GO:0032880; P:regulation of protein localization
GO:0006417; P:regulation of translation
GO:0034405; P:response to fluid shear stress
GO:0032094; P:response to food
GO:0070141; P:response to UV-A
GO:0051146; P:striated muscle cell differentiation
GO:0006412; P:translation
KEGG
rno:24185;
InterPros
IPR000961; AGC-kinase_C.
IPR011009; Kinase-like_dom.
IPR011993; PH_like_dom.
IPR017892; Pkinase_C.
IPR001849; Pleckstrin_homology.
IPR000719; Prot_kinase_cat_dom.
IPR017441; Protein_kinase_ATP_BS.
IPR002290; Ser/Thr_dual-sp_kinase_dom.
IPR008271; Ser/Thr_kinase_AS.
Pfam
PF00169; PH; 1.
PF00069; Pkinase; 1.
PF00433; Pkinase_C; 1.
SMARTs
SM00233; PH; 1.
SM00133; S_TK_X; 1.
SM00220; S_TKc; 1.
Prosites
PS51285; AGC_KINASE_CTER; 1.
PS50003; PH_DOMAIN; 1.
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
Prints
Created Date20-Feb-2013